Age (years) | 48 ±15 |
BMI | 26 ±3.7 |
Female (%) | 48 |
Male (%) | 52 |
Diabetes (%) | 14 |
Hypertension (%) | 12 |
Other co-morbidities*(%) | 11 |
HCV RNA quantitative* | 2066.45±4000 |
ALT (IU/L) | 53.5±40 |
AST (IU/L) | 48±29 |
AFP (IU/L) | 4.3±3.4 |
Albumin (g/dL) | 4.1±0.5 |
Total bilirubin (mg/dL) | 0.75±0.4 |
Indirect bilirubin (mg/dL) | 0.48±0.4 |
WBCx103/mm3 | 7.1±2.2 |
Hb (g/dL) | 13.5±1.8 |
Creatinine (mg/dL) | 0.9±0.2 |
INR | 1.1±0.1 |
Platelets×103/mm3 | 231.7±72 |
Fibrosis stage (F) by TE (%) | F0 (23%) |
F1 (26%) | |
F2 (14 %) | |
F3 (9%) | |
F4 (28%) |